semaglutide menstruation and metformin improve menstrual cyclicity in overweight/obese women with polycystic ovary syndrome: a randomized Does Semaglutide or Tirzepatide Mess

However, the potential long-term benefits of semaglutide on slowing the progression of diabetic nephropathy may represent a lasting positive impact on renal health.

Semaglutide is a GLP-1 receptor agonist initially developed as a medication for diabetes

The management of hypertension in MASLD should be tailored to the specific needs of these patients, considering the interplay between liver dysfunction, metabolic derangements, and cardiovascular risks

Preclinical research indicates that GIPR activation also modulates lipid metabolism in adipose tissue and contributes to weight reduction through mechanisms distinct from GLP-1R pathways

J., Khutoryansky, N., Zdravkovic, M., Sprenger, C

and A.C.T.d.C.G.O